FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/07/055258 [Registered on: 16/07/2023] Trial Registered Prospectively
Last Modified On: 14/07/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Screening
Process of Care Changes 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   comparative study of shatapushpa taila nasya & shatapushpa churna in artavakshya 
Scientific Title of Study   comparative efficacy of shatapushpa taila nasya & shatapushpa churna in artavakshaya 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Lalita Prajapat 
Designation  MS Scholar 
Affiliation  Banaras Hindu University Varanasi ,Uttar Pradesh 221005 india 
Address  Department of Prasuti Tantra Faculty of Ayurveda Institute of Medical Science Banaras Hindu University Varanasi ,Uttar Pradesh 221005 india
Department of Prasuti Tantra Faculty of Ayurveda Institute of Medical Science Banaras Hindu University Varanasi ,Uttar Pradesh 221005 india
Varanasi
UTTAR PRADESH
221005
India 
Phone  8619747311  
Fax    
Email  drlalita015@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof dr Deepa Mishra 
Designation  Professor 
Affiliation  Banaras Hindu University Varanasi ,Uttar Pradesh 221005 india 
Address  Department of Prasuti Tantra Faculty of Ayurveda Institute of Medical Science Banaras Hindu University Varanasi ,Uttar Pradesh 221005 india
Department of Prasuti Tantra Faculty of Ayurveda Institute of Medical Science Banaras Hindu University Varanasi ,Uttar Pradesh 221005 india
Varanasi
UTTAR PRADESH
221005
India 
Phone  9650453095  
Fax    
Email  deepa1971mishra@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof dr Deepa Mishra 
Designation  Professor 
Affiliation  Banaras Hindu University Varanasi Uttar Pradesh 
Address  Department of Prasuti Tantra Faculty of Ayurveda Institute of Medical Science Banaras Hindu University Varanasi ,Uttar Pradesh 221005 india
Department of Prasuti Tantra Faculty of Ayurveda Institute of Medical Science Banaras Hindu University Varanasi ,Uttar Pradesh 221005 india
Varanasi
UTTAR PRADESH
221005
India 
Phone  9650453095  
Fax    
Email  deepa1971mishra@gmail.com  
 
Source of Monetary or Material Support  
Sir Sunderlal Hospital Faculty of Ayurveda Varanasi Uttar Predesh 
 
Primary Sponsor  
Name  Dr Lalita Prajapat 
Address  Depatment of Prasuti Tantra Faculty if Ayurveda Institute of Medical Science Banaras Hindu University uttar predesh  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Lalita Prajapat  Opd no 24. Sir Sunderlal Hospital Varanasi uttar pradesh  Department of Prasuti Tantra Faculty of Ayurveda Institute of Medical Science sir Sunderland hospital uttar pradesh
Varanasi
UTTAR PRADESH 
8619747311

drlalita015@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E663||Overweight. Ayurveda Condition: Hypo-oligomenorrhea, (2) ICD-10 Condition:E282||Polycystic ovarian syndrome. Ayurveda Condition: Hypo-oligomenorrhea,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: shatpushpa churna shatpushpa tail, Reference: kashyapsamhita khil sthan, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: milk), Additional Information: -shatpushpa taila Nasya 8drop each nostril
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  Age group 18- 40 yrs.
Interval between two menstrual cycles is greater than 35 days. (for the last 6 months approximately)
The duration of menstrual flow is 2 days or less. .(for the last 6 months approximately)
The quantity of menses is less than 20 ml.
Poly Cystic Ovarian Disease (PCOD) with the symptom of oligomenorrhea and hypomenorrhea.
 
 
ExclusionCriteria 
Details  Patients below the age of 18 years and above the age of 40 years.
Positive history of venereal diseases (HIV, HBsAg, Anti HCV, VDRL, HPV, Genital herpes, etc.)
Pregnant women, lactating mothers.
Poly Cystic Ovarian Disease (PCOD) with menorrhagia.
Patient having organic pathology of uterus & adnexa like cervical carcinoma or any malignant growth.
Patients will not give consent to participate in the study.
Patients using oral contraceptive pills.
Patients who cannot attend follow-up regularly. Who is participating in another study.
Women suffering from Nasal polyp, D.N.S.(Deviated nasal septum), Rhinitis. Nasal tumor, and history of nasal surgery previous.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Regular Menstrual Cycle Improvement of quality of life
 
Every 4weeks 
 
Secondary Outcome  
Outcome  TimePoints 
1.Interval between two cycles (intermenstrual period/Duration between two Artava darshana)
2.Amount of menstrual flow (Artava strava pramana )
3.Pain during menses (Yoni vedana)
Quality of life
 
90days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/07/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  28/07/2023 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

In the present scenario menstrual disorder is the commonest gynecological problem in females of the reproductive age group. On account of the disturbance in intake of proper diet and rest, stress, and strain with the change of lifestyle, menstrual disorders have become a very challenging problem for working women or housewives. They may involve structural or functional disturbances and are mostly associated with the complaint of infertility, psychological problems, obesity, etc.

Nowadays in modern science scanty (Hypomenorrhea) and infrequent menstruation (oligomenorrhea) are treated by hormonal therapy and long-term use of these drugs may produce many side effects.

Artavakshaya may be correlated with oligomenorrhea and hypomenorrhea. In the Ayurvedic classic various Shamana and Shodhana drugs are described for Artavakshaya. Ayurvedic medicines cure Artavakshaya by improving agni and remove of Shrotorodha by using these potent Ayurvedic medicines. Side effects of the allopathic treatment can be avoided. Single-drug therapy can be taken easily by females during their busy schedules. Therefore, the present study is undertaken to evaluate and compare the effect of Shatapushpa Taila Nasya and Shatapushpa Churna in the management of Artavakshaya.

 
Close